Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03615508 · ClinicalTrials.gov registry record · Phase 4
Exploration of Pupil Dilation in Horner's Patients Taking Flomax
A Phase 4 study, sponsored by Denver Health and Hospital Authority.
- Terminated
- Registry status
- Phase 4
- Development phase
- 1
- Enrollment target
NCT03615508 is a Phase 4 study that was terminated before completion, run by Denver Health and Hospital Authority. The registered enrollment target is 1 participants.
The verdict
NCT03615508, a Phase 4 study, was terminated before completion, sponsored by Denver Health and Hospital Authority.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 1 participants
- Enrollment target
Study Summary
This study is evaluating the pupil dilation of Horner's Patients who have ever taken an alpha blocker such as Tamsulosin. Patients will undergo eye dilation as would occur at a yearly eye examination, but their pupil dilation measurements will be recorded.
Interventions
- DRUG 10% phenylephrine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2018-09-21 |
| Est. Completion | 2019-05-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03615508
The ClinicalTrials.gov registry entry for NCT03615508 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Denver Health and Hospital Authority, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 10% phenylephrine is the first listed.
NCT03615508 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03615508 about?
NCT03615508 is a clinical study titled "Exploration of Pupil Dilation in Horner's Patients Taking Flomax". This study is evaluating the pupil dilation of Horner's Patients who have ever taken an alpha blocker such as Tamsulosin. Patients will undergo eye dilation as would occur at a yearly eye examination, but their pupil dilation measurements will be recorded.
What is the current status of trial NCT03615508?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 1 participants. The study started on 2018-09-21. Estimated completion is 2019-05-01.
What interventions are being tested in trial NCT03615508?
The interventions under investigation include: 10% phenylephrine (DRUG).
Who is sponsoring clinical trial NCT03615508?
This trial is sponsored by Denver Health and Hospital Authority, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.